9 Meters Biopharma Other Current Liabilities

9 Meters Biopharma (NMTRQ) currently reports a other current liabilities of $6.2M as of March 2023. That compares with $6.3M in the prior-year period — down 0.7% year over year. Use the charts on this page to explore 9 Meters Biopharma's other current liabilities history and peer comparisons.

9 Meters Biopharma's other current liabilities decreased from $6.3M to $6.2M — a 0.7% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

9 Meters Biopharma reported $6.2M in other current liabilities as of March 2023. That compares with $6.3M in the prior-year period — down 0.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $6.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 9 Meters Biopharma, and consider following NMTRQ for alerts when major investors trade the stock.

9 Meters Biopharma is classified in the Technology sector. On other current liabilities, it currently shows $6.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NMTRQ with unrelated industries.